Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2025 | 04-2024 | 04-2023 | 04-2022 | 04-2021 | |
| Sales | 56,944 | 50,155 | 53,870 | 49,109 | 41,040 |
| Cost of Goods | 28,389 | 29,401 | 29,532 | 23,632 | 21,446 |
| Gross Profit | 28,555 | 20,754 | 24,338 | 25,477 | 19,594 |
| Operating Expenses | 24,391 | 28,511 | 30,126 | 25,502 | 19,674 |
| Operating Income | 4,553 | -7,356 | -5,256 | 607 | 366 |
| Other Income | 73 | 48 | -11 | -24 | 71 |
| Pre-tax Income | 4,626 | -7,308 | -5,267 | 583 | 437 |
| Income Tax | -75 | -32 | 68 | 35 | 75 |
| Net Income Continuous | 4,701 | -7,276 | -5,335 | 548 | 362 |
| Net Income | $4,701 | $-7,276 | $-5,335 | $548 | $362 |
| EPS Basic Total Ops | 0.34 | -0.54 | -0.39 | 0.04 | 0.03 |
| EPS Basic Continuous Ops | 0.34 | -0.54 | -0.39 | 0.04 | 0.03 |
| EPS Diluted Total Ops | 0.33 | -0.54 | -0.39 | 0.04 | 0.02 |
| EPS Diluted Continuous Ops | 0.33 | -0.54 | -0.39 | 0.04 | 0.02 |
| EPS Diluted Before Non-Recurring Items | 0.33 | -0.54 | -0.39 | 0.04 | 0.02 |
| EBITDA(a) | $6,193 | $-5,489 | $-3,010 | $2,234 | $1,550 |